Clinical Development Vision and Strategy
We will think about how to read changes in the environment and provide better medical products to patients as soon as possible, and will do our utmost to develop without being bound by precedents.
Transformation in development
In developing a vaccine and therapeutic drugs for COVID-19
we are holding daily discussions, including with senior management, about which patients would receive such solutions, how fast we could provide them, and what kind of development plan we should have for accomplishing this. As we proceed, we are communicating with the regulatory authorities more closely than in the past, and we are discussing how to execute our development plan as soon as possible and based on science.
Eight development pipelines that causes paradigm shifts
Our top priority remains to deliver a COVID-19 vaccine and therapeutic drugs as soon as possible, and we are working on the development of based on core eight projects so that we can provide innovative value.
Shionogi is progressing development in eight core pipeline projects, aiming to deliver innovative value that clearly embodies new approaches, not just incremental improvements.